日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD36-mediated endocytosis of proteolysis-targeting chimeras.

CD36介导的靶向蛋白水解嵌合体的内吞作用

Wang Zhengyu, Pan Bo-Syong, Manne Rajesh Kumar, Chen Jungang, Lv Dongwen, Wang Minmin, Tran Phuc, Weldemichael Tsigereda, Yan Wei, Zhou Hongfei, Martinez Gloria M, Shao Jingwei, Hsu Che-Chia, Hromas Robert, Zhou Daohong, Qin Zhiqiang, Lin Hui-Kuan, Li Hong-Yu

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma

基于CRISPR/Cas9基因编辑技术的肝细胞癌研究进展及应用

Yu, Shijing; Zhao, Ruirui; Zhang, Bingchen; Lai, Chunmei; Li, Linyan; Shen, Jiangwen; Tan, Xiarong; Shao, Jingwei

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing

单细胞RNA测序揭示肺腺癌和鳞状细胞癌之间免疫图谱的异质性

Chengdi Wang # ,Qiuxiao Yu # ,Tingting Song # ,Zhoufeng Wang ,Lujia Song ,Ying Yang ,Jun Shao ,Jingwei Li ,Yinyun Ni ,Ningning Chao ,Li Zhang ,Weimin Li

A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy

一种基于植物和食品来源天然产物共组装的智能双药纳米系统,用于协同治疗肝细胞癌。

Zhang, Bingchen; Jiang, Jiali; Wu, Pengyu; Zou, Junjie; Le, Jingqing; Lin, Juanfang; Li, Chao; Luo, Bangyue; Zhang, Yongjie; Huang, Rui; Shao, Jingwei

Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy

索拉非尼纳米制剂在癌症治疗中的最新进展:智能纳米系统和联合疗法

Chen, Fangmin; Fang, Yifan; Chen, Xiang; Deng, Rui; Zhang, Yongjie; Shao, Jingwei

Optimized protocols for ChIP-seq and deletion mutant construction in Pseudomonas syringae

针对丁香假单胞菌 ChIP-seq 和缺失突变体构建的优化方案

Chunyan Yao,Xiaolong Shao,Jingwei Li,Xin Deng

Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid

从小分子到纳米药物递送系统的演变:熊果酸癌症治疗的新兴方法

Shao, Jingwei; Fang, Yifan; Zhao, Ruirui; Chen, Fangmin; Yang, Mingyue; Jiang, Jiali; Chen, Zixuan; Yuan, Xiaotian; Jia, Lee

Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer

毛兰素对人类结直肠癌细胞生长和吞噬作用的双重靶向作用

Yihan Sun, Guofeng Li, Qi Zhou, Danyue Shao, Jingwei Lv, Jianhua Zhou

Global deregulation of ginseng products may be a safety hazard to warfarin takers: solid evidence of ginseng-warfarin interaction

全球范围内人参产品监管的放松可能对服用华法林的患者构成安全隐患:人参与华法林相互作用的有力证据。

Dong, Haiyan; Ma, Ji; Li, Tao; Xiao, Yingying; Zheng, Ning; Liu, Jian; Gao, Yu; Shao, Jingwei; Jia, Lee

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway

Metapristone(RU486代谢物)通过靶向EGFR介导的PI3K/AKT通路抑制非小细胞肺癌。

Shao, Jingwei; Zheng, Guirong; Chen, Hongning; Liu, Jian; Xu, Aixiao; Chen, Fan; Li, Tao; Lu, Yusheng; Xu, Jianguo; Zheng, Ning; Jia, Lee